Background: While several cell types are known to contribute to bone formation, the major player is a common bone matrix-secreting cell type, the osteoblast. Chondrocytes, which plays critical roles at several stages of endochondral ossification, and osteoblasts are derived from common precursors, and both intrinsic cues and signals from extrinsic cues play critical roles in the lineage decision of these cell types. Several studies have shown that cell fate commitment within the osteoblast lineage requires sequential, stage-specific signaling to promote osteoblastic differentiation programs. In osteoblastic differentiation, the functional mechanisms of transcriptional regulators have been well elucidated, however the exact roles of extrinsic molecules in osteoblastic differentiation are less clear.
Background
The skeleton is a multifunctional system with physiological roles in providing a rigid framework and support, acting as the primary storage site for mineral salts, and functioning in hematopoiesis. While several cell types are known to contribute to bone formation, the major player is a common bone matrix-secreting cell type, the osteoblast.
Chondrocytes, which play critical roles at several stages of endochondral ossification, and osteoblasts are derived from common precursors, and both intrinsic cues and signals from extrinsic cues play critical roles in the lineage decision of these cell types [1] [2] [3] . The targeted mutation of Runx2 or Osterix, transcription regulators highly expressed in osteoblast progenitors, result in the lack of mature osteoblasts, demonstrating that these factors are essential for osteoblastogenesis [4] [5] [6] [7] . Several studies have shown that cell fate commitment within the osteoblast lineage requires sequential, stage-specific, Ihh and canonical Wnt/ -catenin signaling to promote osteoblastic, and also to block chondrogenic, differentiation programs [8] [9] [10] [11] . Another recent report shows that the inhibitory effect of Sox9 on osteoblastic and chondrocyte maturation via repression of Runx2 function is an essential mechanism for osteochondroprogenitor cell fate determination [12] .
Most bones are formed by endochondral ossification in which mesenchymal condensations differentiate into chondrocytes, forming a cartilaginous template prefiguring the future skeletal elements. The perichondrium and perioseum are generated around the nascent cartilage, and cells surrounding the zone of hypertrophic chondrocytes begin to differentiate into osteoblasts. Sox9 is expressed in all chondroprogenitors and chondrocytes except hypertrophic chondrocytes, and is required for the sequential steps of chondrogenesis before and after mesenchymal condensations [13, 14] .
Thus, in osteoblastic differentiation, the functional mechanisms of transcriptional regulators have been well elucidated, however the exact roles of extrinsic molecules in osteoblastic differentiation are less clear. In our microarray screening aiming to identify novel molecular pathways in chondrocyte differentiation, we identified a novel gene encoding a transmembrane protein, which is predominantly expressed in osteoblasts during mouse development. We named this gene obif (osteoblast induction factor) and performed functional analyses using cell culture models.
We found that obif overexpression in the preosteoblastic MC3T3-E1 cells induces differentiation and maturation of osteoblasts. Knockdown of obif suppresses osteoblastic differentiation of MC3T3-E1 cells. We also present data demonstrating that the extracellular domains of both mouse and human obif proteins augment osteoblastic differentiation-induction activity, suggesting that obif acts in a ligand-like manner. Together, our results suggest that obif is involved in the differentiation of osteoblasts through intercellular interaction during development.
Results

Identification and intracellular localization of obif protein
With the aim of identifying novel molecules involved in chondrocyte differentiation, we performed a microarray screening using a mouse chondroprogenitor cell line, ATDC5 ( Figure 1A ). We extracted total RNA at day 0 (the confluence stage), day 9 (the cartilage nodule formation stage), and day 37 (the cellular hypertrophy and calcification stage). With the gene expression profile analysis, we identified 131 probe sets that showed more than a threefold change in expression level at day 9 or day 37 relative to day 0. From among these genes, we selected 25 genes that have not as yet been known to be associated with chondrogenesis and osteoblastogenesis, and further investigated their expression patterns. We found one gene that shows an expression pattern predominantly in the skeletal systems of mouse embryos and up-regulation upon differentiation in ATDC5 cells. On the basis of our functional assay, we named this gene obif (osteoblast induction factor) (GenBank TPA #BC025600) ( Figure 1B ) which is the same gene with transmembrane protein 119 (tmem119).
The deduced amino acid sequence of mouse obif contains a signal sequence, a single transmembrane domain, and a glutamic acid-rich region. This gene is conserved among species from chicken to human ( Figure 1C and Additional file 1). We also isolated a human OBIF cDNA from commercially available human fetal brain RNA by RT-PCR. The genomes of zebra fish and Xenopus tropicalis also contain sequences that are homologous to mouse obif (data not shown). We then examined the subcellular localization of obif. Using a retrovirus vector, we overexpressed a FLAG-tagged obif in various cell lines. To confirm the obif expression, we performed Western blot analysis using anti-FLAG M2 antibody and the antibody that we raised against obif ( Figure 1D ). With both of these antibodies, we detected a strong band of approximately 37 kD, a weak band of approximately 44 kD, and broad bands of 50 -75 kD in all cell lines in which obif was overexpressed ( Figure  1D ). Using the on-line predictor method NetOGlyc 3.1 [15] , we found several potential O-glycosylation sites between the signal sequence and transmembrane domain of obif (Additional file 1). This observation strongly suggests that obif is a type Ia transmembrane protein in which the N-terminal region is frequently modified posttranscriptionally. Next, we examined the intracellular localization of obif using MC3T3-E1 cells stably overexpressing mouse obif (MC3T3-obif) or human OBIF (MC3T3-OBIF) by immunostaining ( Figures 1E-H) . Obif/ OBIF are mainly localized to the plasma membrane. This observation is coincident with the result of Western blot analysis on the subcellular fractionated samples ( Figure  1I ), in which the microsomal fraction contained an abundant amount of obif compared with the cytoplasmic fraction.
Obif transcript is expressed in osteoblast-lineage cells
Early mouse embryos were examined for obif transcript expression by whole mount in situ hybridization ( Figures  2A and 2B) . No clear hybridization signal was detected at E8.5 (data not shown). At E9.5, the signal was seen in the whole limb buds (Figure 2A ). At E12.5, the stage the cartilage primordiums were formed in the limb buds, obif transcripts were observed in the areas between these primordiums ( Figure 2B ).
We then compared the expression of obif with that of the chondrocytic marker Sox9 (Figures 2C-P) . In the forelimb bud, obif is expressed in a broad region at E9.5 ( Figure  2A ). At E10.5 and E11.5, the signal is down-regulated in the proximal region where mesenchymal cells condense and differentiate into chondrocytes, as evidenced by the onset of Sox9 expression (Figures 2C, D , G, and 2H). At E12.5 and E13.5, while Sox9 shows a prominent signal in future digit regions, the expression of obif is most abundant in the interdigital mesenchyme ( Figures 2E, F, I , and 2J). As in developing limb buds, obif expression is complementary to that of Sox9 in other tissues (Figures 2D, H, K-P). For instance, obif is expressed in cells between the condensations that form the future ribs at E11.5 ( Figure 2D ) and in the osteogenic mesenchyme surrounding Meckel's cartilage at E12.5 ( Figures 2K-M) . However, we could not detect obif transcripts in the chondrocyte-lineage cells such as the cartilage condensation and Meckel's cartilage where Sox9 is expressed ( Figures 2C-P) .
To investigate the obif transcript expression at later embryonic stages, we performed section in situ hybridization with several markers pertaining to endochondral ossification ( Figures 2Q-Y) . Collagen1(Col.1) and osteocalcin (ocn) are markers for mature osteoblasts. Osteopontin (opn) is a marker for both terminally differentiated chondrocytes and osteoblasts, and collagen 10 (col.10) is a marker for hypertrophic chondrocytes. Interestingly, the expression of obif was observed in the osteoblasts. In E14.5 humerus, obif transcripts were detected in the perichondrium of the hypertrophic chondrocyte region where collagen1 is expressed, but were absent from more centrally located chondrocytic cells ( Figures 2Q and 2R ). At E15.5, when ocn is not yet significantly expressed, obif is detected both in the prospective bone collar region marked with collagen1 and in the developing bone trabeculae marked with opn ( Figures 2S-V) . At E17.5, obif expression overlaps with ocn but not with collagen10 ( Figures 2W-Y) .
Next, we examined the expression of obif and Runx2 in various tissues of 4 week-old mice by Northern blot analysis ( Figure 2Z ). A 2.1 kb band was detected in the tissues containing osteoblasts (calvaria, long bones) and other tissues such as the brain and lung. The calvaria band was significantly stronger as compared with that of the brain or lung. High levels of obif expression at embryonic stages followed by decreased expression of obif at early postnatal stages suggest that obif works in both embryonic skeletal development and postnatal differentiation. During postnatal development, expression in calvaria and long bones decreases whereas Runx2 expression is comparably maintained ( Figure 2AA ), suggesting that obif does not have an important role in mature adult tissues.
Obif expression is up-regulated during osteoblastic differentiation in cell line models Several cell lines derived from mesenchymal tissues have been widely used to recapitulate in vivo cellular differentiation [16] [17] [18] [19] [20] . We used preosteoblastic MC3T3-E1 cells, Identification of a novel plasma membrane protein, obif, and its subcellular localization 
Endogenous obif protein is expressed in osteoblast-lineage cells
In order to investigate the localization of endogenous obif protein, we immunostained sections of embryonic forelimb and humerus using the anti-obif antibody (Figures 3A-E). Signals were observed in the perichondrium of the hypertrophic chondrocyte region, peripheral layers of the endochondral skeletal elements, and cells associated bone trabeculae including both the spindle-shaped osteoblasts and the cuboidal-shaped osteoblasts. In addition, we observed that obif appears to be expressed in the plasma membrane of osteoblasts ( Figures 3C and 3E ). To verify the expression of obif protein in osteoblast-lineage cells, we performed double staining of the developing limb using the obif antibody with other osteoblastic markers such as alkaline-phosphatase (ALP) and collagen 1 ( 3M ). On the other hand, when densely cultured cells were stimulated with osteoblastic differentiation medium, strong obif expression was detected ( Figures 3K and 3N ). By western blot analysis using primary culture cells and MC3T3-E1 cells, the elevation of the protein level was observed during calvarial cell maturation ( Figure 3P ).
The role of obif in osteoblastogenesis
We then performed cell differentiation analysis using the retrovirus vector. For the overexpression study, cells were infected with retroviruses expressing both obif and GFP through IRES or expressing GFP only as a control. The infection efficiency was monitored by GFP expression (Additional file 2A, D, G, and 2J). Obif expression was confirmed by immunocytochemistry (Additional file 2C and 2I) and Western blot analysis using anti-obif antibody ( Figure 1D ). These results show that cultured cells can be infected efficiently (>95%) with retroviruses. These infected cells express GFP and/or obif protein even after extensive passaging. For gene knockdown, we made retroviruses expressing short hairpin RNAs (shRNAs) against obif. First, we designed three different siRNAs (siRNA-1, Non-transfected MC3T3-obif cells and ATDC5-obif cells were also electrophoresed. All of the siRNAs against obif showed strong knockdown effects (Additional file 3). Next, we made retroviral constructs overlapping the effective siRNA sequences, a control shRNA (sh-cont), sh292 which sequence overlaps siRNA-1 and siRNA-2 sequences, and sh301 which sequence overlaps siRNA-3 sequence. When infected, MC3T3-obif cells with sh292 retroviruses showed a strong knockdown effect and those with sh301 retroviruses showed a comparatively weak knockdown effect (Additional file 3). Using these retroviruses, we established cells stably expressing these shRNAs and performed knockdown studies.
Initially, we examined the effect of obif overexpression on cell growth ( Figures 4A and 4B ). The proliferation rate decreased somewhat in MC3T3-obif cells compared with MC3T3-control (MC3T3-cont) cells ( Figure 4A ). The same effects of exogenous obif were observed in other cell lines, ATDC5, ST2, and C2C12 (data not shown). On the other hand, MC3T3-sh292 and -sh301 cells showed almost the same cell growth as cells infected with control retrovirus (MC3T3-sh-cont) ( Figure 4B ). This result indicates that effect of obif on cell differentiation described below is not mainly due to the effects on cell growth.
Next, we investigated the relationship between obif expression and osteoblast differentiation. We first examined an early stage osteoblastic marker, ALP activity. The retrovirally infected cells were cultured in osteoblast differentiation media and harvested at the indicated time points (Figures 4C and 4D ). While ALP activity increased in a time-dependent manner both in MC3T3-obif and -cont cells, MC3T3-obif cells showed a significantly higher ALP activity than the MC3T3-cont cells at all points examined ( Figure 4C ). In contrast, the reduction of obif expression caused a significant decrease of ALP activity at all time points examined ( Figure 4D ). Second, we cultured MC3T3-E1 cells in the differentiation-induction medium until mineralized nodules could be observed. Mineralization was visualized by Alizarin Red staining and quantified by a biochemical assay for calcium. A significantly higher degree of mineralization was obtained in MC3T3-obif cells than in MC3T3-cont cells ( Figures 4E-H) . A quantitative analysis of calcium by extraction of the calcified mineral also showed a higher calcium content in MC3T3-obif cells ( Figure 4M ). In contrast, decreased mineralization was observed in MC3T3-sh292 cells and MC3T3-sh301 cells as compared with MC3T3-sh-cont cells ( Figures 4I-L and 4N ). In addition, we examined the effect of human OBIF on mineralization and confirmed that it also promoted mineralization (Additional file 4).
Aiming to investigate the effect of obif at the molecular level, we examined the expression of osteoblast lineageassociated genes by Northern blot analysis (Figures 5A-D) . In obif overexpression experiments, the mRNA levels of the osteoblastic differentiation markers increased in MC3T3-obif cells compared with those in MC3T3-cont cells. In particular, the elevations of bsp and ocn mRNA levels were prominent ( Figure 5A ). In knockdown experiments, obif transcripts were almost completely abolished in MC3T3-sh292 cells and partially ablated in MC3T3-sh301 cells (Figures 5B-D) . As early and essential osteoblastic markers, we first examined Runx2 and Osx mRNA levels ( Figure 5B ). At day 14, Osx transcripts decreased in obif knocked down cells whereas Runx2 transcripts were not influenced by obif levels. At day 28, Runx2 was downregulated in MC3T3-sh292 cells while we could detect only faint evidence of obif mRNA. To investigate the relationship between Runx2 and obif, we established Runx2 knocked down MC3T3-E1 cells (MC3T3-shRunx2) and compared with obif knocked down cells ( Figure 5C ). In MC3T3-shRunx2 cells, obif was down-regulated whereas Runx2 was not affected in MC3T3-sh292 cells at day 8. These results concur with a previous report that suggests obif is a downstream gene of Runx2 [21] . Furthermore, obif promoters contain a number of putative Runx2 binding sites in multiple species (Additional file 5). Next, we examined ocn mRNA levels in obif knocked down cells ( Figure 5D ). At day 14 and 28, ocn was down-regulated in both MC3T3-sh292 and -sh301 cell. At day 42, the ocn mRNA level in MC3T3-sh301 cells is almost the same as that in the control cells whereas it is significantly lower in MC3T3-sh292 cells. In primary culture cells, ocn mRNA was down-regulated in obif knocked-down cells ( Figure  5E ).
Extracellular domain of obif can promote osteoblastic differentiation
Obif protein is a single pass transmembrane protein that localizes to the plasma membranes. In order to investigate the mechanism of obif function, we made two more retroviral constructs. One expresses the N-terminal extracellular domain (ECD), and the other expresses both the ECD and the transmembrane domain (TM) ( Figure 6A ). Using retroviruses derived from these constructs, we established cells stably expressing partial obif proteins. Both bands of the partial proteins detected by Western blot were larger than their predicted sizes ( Figure 6B ). Immunocytochemistry analyses using an anti-FLAG antibody showed different subcellular localizations of these genes ( Figures 1F,  6C , and 6D). Proteins including the TM localized to the plasma membranes whereas a large amount of obif-ECD protein localized to the cytoplasm.
Then, we examined the effects of partial obif proteins on the induction of ALP activity and matrix mineralization. MC3T3-ECD and -ECD+TM cells showed strong ALP activities similar to MC3T3-obif cells at all points examined ( Figure 6E ). Partial obif proteins also stimulated mineralization at days 28 and 42 ( Figure 6F ). Similar results were observed in experiments using retroviruses expressing partial proteins of human OBIF (Additional file 6).
Next, we generated an obif-fusion protein, consisting of the obif extracellular domain fused to an AP tag. Bands of predicted sizes were detected in lysates from transfected cells by Western blotting using an anti-AP antibody (Figure 6G ). On the other hand, in supernatants from transfected cells, bands of larger sizes were detected. When tested for binding to tissue sections and cultured cells, APobif (ECD) bound to bone tissues and differentiating MC3T3-E1 cells (Figures 6I, K, and data not shown). In contrast, the control AP protein did not bind at detectable levels ( Figures 6H and 6J ).
Discussion
We have isolated and functionally characterized a novel plasma membrane protein, obif. Obif is highly expressed in early and late stage osteoblasts of developing mouse embryos, and its transcripts increase during osteoblastic differentiation in several skeletal cell lines. In preosteoblastic MC3T3-E1 cells, differentiation, particularly matrix mineralization, is stimulated when obif is overexpressed, and inhibited when obif is knocked down. Furthermore, we showed that the extracellular domain of obif protein can promote MC3T3-E1 differentiation like the fulllength form of obif, suggesting that obif functions in a ligand-like manner.
Although obif was originally isolated as a molecule that is up-regulated during ATDC5 cell differentiation, we could not detect clear obif/obif expression in chondrocyte-lineage cells in mouse skeletal tissues. This seems due to obif up-regulation by cells surrounding the cartilage nodules during ATDC5 differentiation.
Osteoblastogenesis is a multistep process temporally controlled by transcription factors and secreted growth factors. The centerpiece of the transcriptional control of osteoblast differentiation is the Runx2-dependent pathway. Runx2-deficient mice have a cartilaginous skeleton without any osteoblasts, as osteoblast differentiation is arrested as early as E12.5 [6] . Osterix, a zinc finger-containing protein that is known to be downstream of Runx2, is expressed in osteoblast progenitors, and mice without Osterix also lack mature osteoblasts [7] . Although other transcription factors, Dlx5/6, Msx1/2, AP-1 families, twist, and ATF4, have been reported to be involved in osteoblastic differentiation, exact roles of these factors and their relationship with Runx2 remain to be elucidated [22] [23] [24] [25] [26] [27] .
A recent report suggests that obif (tmem119) is one of the molecules downstream of Runx2 [21] . Our results are consistent with this report. However, obif expression is observed as early as Runx2 expression in developing limb buds and during the differentiation of MC3T3-E1 cells. Therefore, the genetic and cell biological relationships between obif and Runx2 will need future studies, including analysis of obif and Runx2 mutant mice.
The effect of obif expression on osteoblastic markers In mouse embryos, cells expressing obif are observed in the periosteum, bone collars, and trabecular bones. The expression pattern of obif suggests that obif functions in osteoblastic development. In the multiple cell line models we used, endogenous obif is markedly upregulated during osteoblastic differentiation. These expression patterns strongly suggest that obif functions in osteoblastogenesis. In committed preosteoblastic MC3T3-E1 cells, obif exerts critical roles both in ALP induction and in matrix mineralization. In obif overexpression and knockdown experiments, cell proliferation is mildly affected but the effect of obif expression levels on differentiation is more significant. Thus we propose that obif may play a role in both proliferation and differentiation, but the primary effect of obif is on differentiation. When obif is knocked down in MC3T3-E1 cells, mRNA levels of Osx and ocn decrease proportionally to the obif transcripts, although Runx2 is not significantly affected. And in a similar experiment using primary calvarial cells, the level of ocn transcript decreases in cells in which obif was knocked down. These results suggest that obif protein is involved in the late differentiation of osteoblast-lineage cells.
Partial proteins including the ECD of both human and mouse obif stimulated osteoblastic differentiation in MC3T3-E1 cells as well as the full-length obif protein.
These results suggest that the ECD is sufficient to stimulate osteoblastic differentiation, and the physiological function of obif is mediated by cell-cell or cell-matrix interaction as a ligand. The binding activity of AP-obif (ECD) to bone tissues and differentiating MC3T3-E1 cells supports the hypothesis that an obif receptor-like molecule exists in bone tissues and that obif functions as a ligand. Further investigation of the functional mechanisms of obif may shed light on a new signaling mechanism in osteoblast and chondrocyte differentiation.
Conclusions
Methods
Reagents
Cell culture medium, -modified minimum essential medium ( -MEM), Dulbecco's modified Eagle's medium (DMEM), a 1:1 mixture of DMEM and Ham's F-12 medium, ascorbic acid, -glycerophosphate, and ITS Liquid Media Supplement were purchased from Sigma. Fetal bovine serum (FBS) was purchased from JRH Bioscience (Nichirei, Japan). The following primary antibodies were used: anti-FLAG M2 (Sigma), anti--actin clone AC-74 (Sigma), anti-collagen type I (Santa Cruz). Wnt3a-conditioned medium was kindly provided by Dr. Shin Yonehara (Kyoto University). Recombinant human BMP2 was provided by Osteopharma Inc. (Osaka). Obif siRNA (Stealth™ RNAs) duplexes were chemically synthesized by Invitrogen. The obif siRNA sequences were as follows: siRNA-1, GCUCGCUGACCUUCCUCAUCAUGUU; siRNA-2, UCGCUGACCUUCCUCAUCAUGUUCA; siRNA-3, CCUUCCUCAUCAUGUUCAUAGUCUG.
Anti-obif antibody production By using PCR, a cDNA encoding a C-terminal portion of mouse obif (residues 113-280; obif-C) was amplified and subcloned into pGEX4T-1 (Amersham Biosciences). The fusion was expressed in Escherichia coli strain DH5 and purified with glutathione Sepharose 4B (Amersham Biosciences) according to the manufacturer's instructions. An antibody against obif was obtained by immunizing rabbits with the purified GST-obif-C (MBL, Japan). The rabbit antisera against obif-C was pre-absorbed with GST-Sepharose and affinity purified with an immunizing fusion protein-bound Sepharose column. Microarray gene expression profiles RNA was harvested and purified with Trizol according to manufacturer's protocol (Invitrogen). Preparation of cRNA and hybridization of probe arrays were performed according to the protocols of the manufacturer using the GeneChip Mouse Genome 430 2.0 Array (Affymetrix, Santa Clara, CA).
Cell culture
Production of recombinant retrovirus and infection
The retroviral vector expressing mouse or human obif was constructed in the pBMN-I-GFP vector that was kindly provided by Dr. Gary Nolan (Stanford University). In brief, the full-or partial-length coding regions of mouse or human obif cDNA that were added to the FLAG tag at the C-terminus were inserted into the multicloning site of pBMN-I-GFP. PCR were performed using FANTOM clone [28] cDNA (#BC025600) or cDNA produced from Human Fetal Brain Total RNA (purchased from Clontech). Reduction of obif expression was achieved through the retroviral infection of cells with short hairpin RNAs directed against the obif mRNA, using pSU-PER.retro.neo+GFP (pSUP) plasmids (Oligoengine). 19-nt target sequences were selected in the mouse obif and Runx2 cDNA coding sequences as follows: obif sh292, 5'-CGCTGACCTTCCTCATCAT-3' (292-310); obif sh301, 5'-TCCTCATCATGTTCATAGT-3' (301-319); Runx2, 5'-CCACTTACCACAGAGCTAT-3' (857-875). Each one was used to design a 60-nt oligo, which was subcloned between the BglII and HindIII restriction sites of the pSUP vector according to the manufacturer's instructions. As a control, the same set of experiments was performed using an irrelevant sequence (Dharmacon Research). To produce the retroviral particles, the plasmid DNA was transfected along with a helper plasmid into a subline of the 293T cell line; supernatant was collected every day starting at 24 hr posttransfection for 3 days. For infection, cells plated at low density were incubated in virus-conditioned medium for 1-2 days in the presence of 8 g/ml polybrene. Virus-conditioned medium was used in a 1:1 dilution with normal growth medium. In the case of infection with retroviruses expressing shRNA, infected cells were selected based on their resistance to G418.
Western blot analysis
Cells were harvested in lysis buffer (50 mM Tris-HCL [pH7.5], 0.15 M NaCl, containing 1% NP-40, 1 M sodium orthovanadate). After sonication, cell debris was removed by centrifugation, and the supernatants were collected. Equal amounts of total proteins were then prepared for Western blot analysis according to a previously described protocol [29] . The primary antibody dilutions were 1:1000 (anti-FLAG M2), 1:500 (anti-obif), and 1:5000 (anti--actin).
Subcellular localization analysis
Stably infected cells were used for localization analysis according to a previously described protocol [29] . The primary antibodies were used at dilutions of 1:500 (anti-FLAG M2) and 1:250 (anti-obif). For nuclear staining, we added 4,6, -diamidino-2-phenylindole dihydrochloride (DAPI, Sigma) at a dilution of 1:1000 in the secondary antibody solution.
Subcellular fractionation
Cells were harvested in ice-cold buffered sucrose (0.25 M. sucrose-10 mM Tris-HCl buffer [pH 7.5]) and whole-cell lysates prepared by sonication were centrifuged in a swinging bucket rotor at 80 × g for 5 min at 4°C. Then the supernatant was spun at 12,000 × g for 10 min. The resultant pellet was designated the mitochondrial fraction. The postmitochondrial supernatant was then subjected to centrifugation at 100,000 × g for 90 min in a Beckman TLA120.2 rotor at 4°C. The high-spin pellet was designated the microsomal fraction, and the supernatant was designated the cytoplasmic fraction.
In situ hybridization and Northern blot analysis
Mouse obif (#BC025600), Sox9 (#4933413I11), and collagen1 (#D930048E22) cDNAs obtained from the RIKEN FANTOM2 collection were used to prepare antisense probes. A 540 bp fragment of mouse collagen2 and a 520 bp fragment of mouse collagen10 were obtained by RT-PCR and subcloned into the pGEM-T Easy vectors (Promega). Mouse osteopontin and osteocalcin cDNAs were kindly provided by Dr. Toshihisa Komori (Nagasaki University, Japan). Whole mount in situ hybridization and section in situ hybridization were performed as described previously [30] . Northern blot hybridization was performed as described previously [31] . The entire protein coding regions of obif, bsp, a 1-kb fragment of Runx2 cDNA (nucleotides 280-1281), a 0.5-kb fragment of Osterix cDNA (nucleotides 115-611), and a 0.47-kb fragment of ocn cDNA (nucleotides 1-470) were used as radiolabeled probes.
Immunohistochemistry
We followed the immunostaining procedures described previously [32] . The specimens were observed under a laser confocal microscope (LSM510, Carl Zeiss) or a fluorescent microscope (Axioskop 2 Plus, Carl Zeiss).
Proliferation assay
Cells were plated at a density of 3 × 10 3 cells/cm 2 and cultured in growth medium. At each time point, cells were harvested and counted using a haemocytometer. Duplicate measurements were performed on three independent wells for each time point.
Osteoblastic differentiation MC3T3-E1 cells, ST2 cells: Cells were plated in 6-well or 12-well plates in triplicate at a density of 2.5 × 10 4 cells/ cm 2 and were cultured in growth medium. One day after the cells reached confluence, they were cultured in differentiation medium ( -MEM containing 50 ug/ml ascorbic acid and 2 mM -glycerophosphate) or Wnt3a-conditioned medium that was used at a 1: 3 dilution with normal growth medium. Determination of ALP activity, Alizarin Red S staining and Ca 2+ accumulation was done as described elsewhere [33, 34] . C2C12 cells: For BMP2 induction, cells were cultured in medium supplemented with 2.5% FBS and 300 ng/ml recombinant human BMP2.
Chondrogenic differentiation
After ATDC5 cells were plated in 6-well or 12-well plates in triplicate at a density of 2.5 × 10 4 cells/cm 2 , differentiation induction and evaluation of matrix proteoglycan synthesis were performed as described elsewhere [35] .
Semi-quantitative RT-PCR
One g samples of RNA were subjected to reverse transcription with a random hexamer as a primer, and semiquantitative PCR was performed for each gene using the following primers: for mouse runx2, 5'-AAATGCCTC-CGCTGTTATGAA (sense primer) and 5'-GCTCCG-GCCCACAAATCT (antisense primer); for mouse collagen 1, 5'-CCCAAGGAAAAGAAGCACGTC (sense primer) and 5'-AGGTCAGCTGGATAGCGACATC (antisense primer); for mouse ocn, 5'-CCGGGAGCAGTGTGAGCTTA (sense primer) and 5'-AGGCGGTCTTCAAGCCATACT (antisense primer); and for mouse -actin 5'-CGTGCGTGACAT-CAAAGAGAA (sense) and 5'-TGGATGCCACAGGATTC-CAT (antisense). PCR conditions were 28 cycles of 94°C for 20 sec, 55°C for 30 sec, and 72°C for 30 sec. Post PCR, each sample was subjected to electrophoresis on a 2% agarose gel and visualized by ethidium bromide staining.
Statistical analysis
Data were examined for distribution, variance homogeneity (F-test) and analyzed using Student's unpaired t-test (2 tailed) for all analyses. P < 0.05 was considered statistically significant. Unless otherwise specified, all data are presented as mean ± SEM or mean + SE.
Production of the AP tag-obif fusion protein We followed the procedures described previously [36] . Briefly, AP fusion proteins were produced by inserting the extracellular domain of obif into the APtag-5 vector that was kindly provided by Dr. Mitsuharu Hattori (Nagoya City University). After producing conditioned medium from transiently transfected 293T cells, we spun out debris and filtered (0.45-m pore size) the supernatant.
In situ analysis of AP tag-obif binding to tissue sections
We washed the sections in HBS and in HBAH buffer. AP fusion proteins were added and incubated at room temperature for 90 min. After a 15 min incubation in preheated HBS, in a 65° water bath, BCIP/NBT substrate was added.
